Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 655,243Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Latisse

02 8Lumigan/Ganfort

PharmaCompass

01

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2020 Revenue in Millions : 378

2019 Revenue in Millions : 0

Growth (%) : 100

Abbvie Company Banner

02

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2021 Revenue in Millions : 579

2020 Revenue in Millions : 378

Growth (%) : 53

Abbvie Company Banner

03

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2022 Revenue in Millions : 514

2021 Revenue in Millions : 579

Growth (%) : -11

Abbvie Company Banner

04

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2023 Revenue in Millions : 432

2022 Revenue in Millions : 514

Growth (%) : -16

Abbvie Company Banner

05

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2017 Revenue in Millions : 689

2016 Revenue in Millions : 688

Growth (%) : 0.1

Abbvie CB

06

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2018 Revenue in Millions : 684

2017 Revenue in Millions : 689

Growth (%) : -1%

Abbvie CB

07

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2016 Revenue in Millions : 688

2015 Revenue in Millions : 544

Growth (%) : 26

Abbvie CB

08

Brand Name : Latisse

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Hypotrichosis of Eyelashes

Currency : USD

2017 Revenue in Millions : 65

2016 Revenue in Millions : 86

Growth (%) : -25

Abbvie CB

09

Brand Name : Lumigan/Ganfort

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Ophthalmology

Currency : USD

2019 Revenue in Millions : 630

2018 Revenue in Millions : 684

Growth (%) : -8

Abbvie CB

10

Brand Name : Latisse

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Bimatoprost

Main Therapeutic Indication : Hypotrichosis of Eyelashes

Currency : USD

2016 Revenue in Millions : 86

2015 Revenue in Millions : 73

Growth (%) : 18

Abbvie CB